+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Infection Diagnostics Market by Technology (Immunoassay, Microbiological Culture, Molecular Diagnostics), Sample Type (Blood, Nasal Swab, Saliva), Test Mode, Infection Type, End User - Global Forecast 2025-2030- Product Image
Respiratory Infection Diagnostics Market by Technology (Immunoassay, Microbiological Culture, Molecular Diagnostics), Sample Type (Blood, Nasal Swab, Saliva), Test Mode, Infection Type, End User - Global Forecast 2025-2030- Product Image
Sale

Respiratory Infection Diagnostics Market by Technology (Immunoassay, Microbiological Culture, Molecular Diagnostics), Sample Type (Blood, Nasal Swab, Saliva), Test Mode, Infection Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012371
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory infection diagnostics market is rapidly evolving in response to changes in global healthcare needs, pathogen emergence, and shifting regulatory and trade landscapes. Senior leaders must navigate complex challenges and advancements to sustain growth and maintain resilience in this sector.

Market Snapshot: Respiratory Infection Diagnostics Market

The Respiratory Infection Diagnostics Market grew from USD 82.35 billion in 2024 to USD 88.38 billion in 2025. It is expected to continue growing at a CAGR of 7.18%, reaching USD 124.87 billion by 2030. Market expansion is being driven by innovation in rapid and multiplex technologies, ongoing public health demands, and global shifts in healthcare delivery. Senior decision-makers will find actionable intelligence in the forces steering diagnostics procurement and deployment worldwide.

Scope & Segmentation

  • Technology: Includes Immunoassay (Enzyme Linked Immunosorbent Assay, Lateral Flow Immunoassay), Microbiological Culture (Automated Culture Systems, Conventional Culture), Molecular Diagnostics (Loop Mediated Isothermal Amplification, Polymerase Chain Reaction), and Sequencing (Next Generation Sequencing, Sanger Sequencing).
  • Sample Types: Blood, Nasal Swab, Saliva, Sputum, Throat Swab.
  • Test Modes: Laboratory Based, Point of Care.
  • Infection Types: Coronavirus Disease, Influenza, Respiratory Syncytial Virus.
  • End User Applications: Clinics, Home Care Settings, Hospitals, Research Laboratories.
  • Regions Covered: Americas (including United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Profiles: F. Hoffmann-La Roche AG, Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, bioMérieux SA, Hologic Inc., QIAGEN N.V., Quidel Corporation, Becton, Dickinson and Company.

Key Takeaways

  • Innovation in rapid diagnostic assays and molecular platforms is improving turnaround time for clinical decision-making and public health surveillance.
  • Diversified sample types and flexible test modes enable greater adaptability for both established laboratories and decentralized settings, meeting rising demand for accessible diagnostics.
  • Heightened regulatory attention is aligning analytical performance and quality assurance to foster global confidence and harmonize standards.
  • Resilience in supply chains is a strategic necessity, with industry players diversifying material sources and forging local and regional collaborations.
  • Integration of digital connectivity with diagnostic platforms is streamlining both test result reporting and large-scale epidemiological tracking, enhancing actionable insight at scale.
  • Strategic partnerships among assay developers, public health agencies, and technology providers are accelerating deployment of assays that target both legacy and novel pathogens.

Tariff Impact on Market Dynamics

Recent adjustments to United States tariff policies have increased the complexity of respiratory diagnostic supply chains. Companies are expanding supplier diversity, exploring domestic manufacturing, and adopting new inventory management strategies to buffer against import duties and mitigate supply disruptions. These changes are influencing the procurement approach and driving a broader trend towards geographically distributed production models in the industry.

Methodology & Data Sources

This report leverages a systematic review of public literature, regulatory filings, and peer-reviewed research, incorporating primary interviews with industry experts and laboratory directors. Analytical rigor is assured through competitive benchmarking, scenario planning, and peer validation. Strict quality controls and data privacy standards uphold research integrity throughout.

Why This Report Matters

  • Informs executive-level decision-making by mapping strategic opportunities, risk factors, and regulatory changes in the respiratory infection diagnostics market.
  • Enables tailored growth strategies across technology platforms, sample types, and global regions, enhancing portfolio and supply chain resilience.
  • Equips leaders to optimize resource allocation, respond proactively to policy changes, and capture new value by adopting emerging diagnostic solutions.

Conclusion

The respiratory infection diagnostics market is undergoing rapid transformation, shaped by global health shifts, regulatory evolution, and supply chain adaptation. Informed strategy and agile innovation are essential for sustained leadership in this dynamic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of multiplex PCR platforms enabling simultaneous detection of multiple respiratory pathogens
5.2. Increasing integration of cloud-based data analytics to monitor respiratory infection outbreaks in real time
5.3. Emergence of CRISPR-based diagnostics for ultra-sensitive detection of emerging respiratory viruses at point of care
5.4. Rising demand for multiplex antigen testing to differentiate between COVID-19 influenza and RSV during respiratory season
5.5. Growth of decentralized testing initiatives driven by portable isothermal amplification technologies and lateral flow assays
5.6. R&D focus on host biomarker assays to distinguish bacterial coinfections in severe respiratory disease management
5.7. Adoption of next-generation sequencing workflows for comprehensive respiratory pathogen profiling and variant surveillance
5.8. Strategic partnerships between diagnostic firms and telehealth platforms to expand remote respiratory infection testing services
5.9. Regulatory approvals accelerating market entry of novel point-of-care molecular tests for rapid respiratory virus identification
5.10. Investment in AI-powered pattern recognition tools to predict respiratory infection trends from diagnostic and clinical data
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Infection Diagnostics Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. Enzyme Linked Immunosorbent Assay
8.2.2. Lateral Flow Immunoassay
8.3. Microbiological Culture
8.3.1. Automated Culture Systems
8.3.2. Conventional Culture
8.4. Molecular Diagnostics
8.4.1. Loop Mediated Isothermal Amplification
8.4.2. Polymerase Chain Reaction
8.5. Sequencing
8.5.1. Next Generation Sequencing
8.5.2. Sanger Sequencing
9. Respiratory Infection Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Nasal Swab
9.4. Saliva
9.5. Sputum
9.6. Throat Swab
10. Respiratory Infection Diagnostics Market, by Test Mode
10.1. Introduction
10.2. Laboratory Based
10.3. Point Of Care
11. Respiratory Infection Diagnostics Market, by Infection Type
11.1. Introduction
11.2. Coronavirus Disease
11.3. Influenza
11.4. Respiratory Syncytial Virus
12. Respiratory Infection Diagnostics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care Settings
12.4. Hospitals
12.5. Research Laboratories
13. Americas Respiratory Infection Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Respiratory Infection Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Respiratory Infection Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Danaher Corporation
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Abbott Laboratories
16.3.5. Siemens Healthineers AG
16.3.6. bioMérieux SA
16.3.7. Hologic Inc.
16.3.8. QIAGEN N.V.
16.3.9. Quidel Corporation
16.3.10. Becton, Dickinson and Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY INFECTION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESPIRATORY INFECTION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESPIRATORY INFECTION DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. RESPIRATORY INFECTION DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. RESPIRATORY INFECTION DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. RESPIRATORY INFECTION DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RESPIRATORY INFECTION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY NASAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SPUTUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY THROAT SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY THROAT SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CORONAVIRUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESPIRATORY SYNCYTIAL VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 122. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 123. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 124. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 125. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 126. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 127. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 128. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 129. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 132. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 133. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 140. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 141. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 146. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 147. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 233. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 234. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 235. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. GERMANY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 251. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 252. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 253. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 256. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 257. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 262. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 263. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. FRANCE RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TEST MODE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 286. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 287. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2018-2024 (USD MILLION)
TABLE 288. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL CULTURE, 2025-2030 (USD MILLION)
TABLE 289. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
TABLE 292. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SEQUENCING, 2025-2030 (USD MILLION)
TABLE 293. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. ITALY RESPIRATORY INFECTION DIAGNOSTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Respiratory Infection Diagnostics market report include:
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • bioMérieux SA
  • Hologic Inc.
  • QIAGEN N.V.
  • Quidel Corporation
  • Becton, Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 88.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 124.87 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Human Metapneumovirus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Human Metapneumovirus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Acute Care Syndromic Testing Market by Syndromic Panel, Product Type, End User, Technology, Application - Global Forecast to 2030 - Product Image

Acute Care Syndromic Testing Market by Syndromic Panel, Product Type, End User, Technology, Application - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Metapneumovirus Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR Based Diagnostics, Microarray Technology), By End-use (Hospitals & Clinics, Diagnostic & Reference Laboratories), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 160 Pages
  • Global
From
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test Type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030 - Product Image

Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test Type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030

  • Report
  • 404 Pages
  • Global
From
Global Respiratory Disease Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Respiratory Disease Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.